SPARK Denmark is a mentoring program that supports early stage academic inventions towards commercialization with education, mentorship and funding. It was founded in 2022 by Novo Nordisk Fonden and is based on the highly successful SPARK program developed at Stanford University.

Our mission is to accelerate the translation of academic inventions into outstanding medical products including novel drugs, repurposing drugs, advanced therapy medicinal products, such as cell and gene therapies, diagnostics and medical devices.

SPARK Denmark is a collaboration between: